Drug Profile
NS 220
Alternative Names: NS-220; R 1593Latest Information Update: 24 May 2010
Price :
$50
*
At a glance
- Originator Nippon Shinyaku
- Class Antihyperlipidaemics; Dioxanes; Oxazoles; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atherosclerosis; Lipid metabolism disorders; Type 2 diabetes mellitus
Most Recent Events
- 24 May 2010 Discontinued - Preclinical for Atherosclerosis in Japan (unspecified route)
- 24 May 2010 Discontinued - Preclinical for Lipid metabolism disorders in Japan (unspecified route)
- 24 May 2010 Discontinued - Preclinical for Type-2 diabetes mellitus in Japan (unspecified route)